Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Human cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.30.526383Source: DataRank Database

Human cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (39)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Adam Z. Cheng ORCID,Ashley A. Auerbach ORCID,Bojana Stefanovska ORCID,Sofia N. Moraes ORCID,James R. Lokensgard ORCID

Live enrichment

PubMed:36778493 OpenAlex:https://openalex.org/W4318677027

National Institutes of Health

Grant: 3T32GM008244-24S1

Medical Scientist Training Program

National Institutes of Health

Grant: 5R37AI064046-14

APOBEC3 Proteins in HIV Restriction

National Institutes of Health

Grant: 5P01CA234228-03

APOBEC MUTAGENESIS IN BREAST CANCER

National Institutes of Health

Grant: 1F31AI161910-01

A dual role for APOBEC counteraction in EBV infection

National Institutes of Health

Grant: 5T32AI083196-12

Minnesota Training Program in Virology

National Institutes of Health

Grant: 5F30CA200432-05

HIV-1 Vif in AIDS-Related Malignancies

greenLicense: cc-by-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/01/31/2023.01.30.526383.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.01.30.526383

repositoryhttp://dx.doi.org/10.1101/2023.01.30.526383

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36778493

Fields of Study

Cytomegalovirus and herpesvirus researchinterferon and immune responsesViral-associated cancers and disorders0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Ribonucleotide reductaseMechanism (biology)RibonucleotideCytomegalovirusVirologyHuman cytomegalovirusChemistryBiologyVirusBiochemistryHerpesviridaeNucleotideProtein subunitViral diseasePhilosophyDNA ReplicationEpstein-Barr Virus InfectionsHerpesvirus 4, HumanAPOBEC3B (A3B); Herpesviruses; Human cytomegalovirus; Immediate-early genes; Innate immunity; Ribonucleotide reductaseInfant, NewbornAPOBEC3B (A3B), herpesviruses, human cytomegalovirus, immediate-early genes, innate immunity, ribonucleotide reductaseHerpesviridae InfectionsHerpesvirus 1, HumanVirus ReplicationArticleVirus-Cell InteractionsImmediate-Early ProteinsMinor Histocompatibility AntigensViral ProteinsCytidine DeaminaseDNA, ViralRibonucleotide ReductasesHumans

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being